{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:22:39Z","timestamp":1786119759175,"version":"build-2736575974"},"reference-count":56,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1097\/bpb.0b013e32833ed967","type":"journal-article","created":{"date-parts":[[2011,3,30]],"date-time":"2011-03-30T03:09:36Z","timestamp":1301454576000},"page":"57-61","source":"Crossref","is-referenced-by-count":19,"title":["Orthopedic complications related to growth hormone therapy in a pediatric population"],"prefix":"10.1097","volume":"20","author":[{"given":"Rachid K.","family":"Haidar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona P.","family":"Nasrallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asdghig H.","family":"Der-Boghossian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismat B.","family":"Ghanem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-13-20210128","first-page":"299","article-title":"Orthopaedic concerns in children with growth hormone therapy.","volume":"70","author":"Docquier","year":"2004","journal-title":"Acta Orthop Belg"},{"key":"R2-13-20210128","first-page":"458","article-title":"Bone diseases in children receiving growth hormone.","volume":"69","author":"Smida","year":"2003","journal-title":"Acta Orthop Belg"},{"key":"R3-13-20210128","first-page":"193","article-title":"Growth hormone and cartilage cell division in hypophysectomized rats.","volume":"4","author":"Kember","year":"1971","journal-title":"Cell Tissue Kinet"},{"key":"R4-13-20210128","first-page":"477","article-title":"Cell kinetics and the control of growth in long bones.","volume":"11","author":"Kember","year":"1978","journal-title":"Cell Tissue Kinet"},{"key":"R5-13-20210128","first-page":"55","article-title":"Growth Hormone and Bone.","volume":"19","author":"Ohlsson","year":"1998","journal-title":"Endocr Rev"},{"key":"R6-13-20210128","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000053087","article-title":"The growth hormone cascade: progress and long-term results of growth hormone treatment in growth hormone deficiency.","volume":"49","author":"Grumbach","year":"1998","journal-title":"Horm Res"},{"key":"R7-13-20210128","first-page":"1868","article-title":"Critical evaluation of the safety of recombinant human growth hormone administration: statement from the Growth Hormone Research Society.","volume":"86","author":"Christiansen","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"R8-13-20210128","first-page":"41","article-title":"Headache, idiopathic intracranial hypertension and slipped capital femoral epiphysis during growth hormone treatment: a safety update from the KIGS database.","volume":"68","author":"Darendeliler","year":"2007","journal-title":"Horm Res"},{"key":"R9-13-20210128","first-page":"31","article-title":"New paradigms for growth hormone therapy in children.","volume":"53","author":"Wetterau","year":"2000","journal-title":"Horm Res"},{"key":"R10-13-20210128","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/BF00444271","article-title":"Slipped capital femoral epiphysis during treatment with recombinant human growth hormone for Turner syndrome.","volume":"114","author":"Sakano","year":"1995","journal-title":"Arch Orthop Trauma Surg"},{"key":"R11-13-20210128","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1067\/mpd.2003.189","article-title":"Adverse events with rhGH treatment of patients with chronic renal insufficiency and end-stage renal disease.","volume":"142","author":"Fine","year":"2003","journal-title":"J Pediatr"},{"key":"R12-13-20210128","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2165\/00002018-199717050-00003","article-title":"A risk-benefit assessment of growth hormone use in children.","volume":"17","author":"Blethen","year":"1997","journal-title":"Drug Saf"},{"key":"R13-13-20210128","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1054\/ghir.2000.0175","article-title":"Safety issues in children and adolescents during growth hormone therapy-a review.","volume":"10","author":"Clayton","year":"2000","journal-title":"Growth Horm IGF Res"},{"key":"R14-13-20210128","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.ecl.2009.06.006","article-title":"Growth hormone: the expansion of available products and indications.","volume":"38","author":"Franklin","year":"2009","journal-title":"Endocrinol Metab Clin N Am"},{"key":"R15-13-20210128","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/BF00866781","article-title":"Is severe renal osteodystrophy a contraindication for recombinant human growth hormone treatment.","volume":"10","author":"Watkins","year":"1996","journal-title":"Pediatr Nephrol"},{"key":"R16-13-20210128","doi-asserted-by":"crossref","first-page":"5247","DOI":"10.1210\/jc.2004-2513","article-title":"Efficacy and safety results of long-term growth hormone treatment of idiopathic short stature.","volume":"90","author":"Kemp","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"R17-13-20210128","doi-asserted-by":"crossref","first-page":"5188","DOI":"10.1210\/jc.2004-2543","article-title":"Safety of growth hormone treatment in pediatric patients with idiopathic short stature.","volume":"90","author":"Quigley","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"R18-13-20210128","first-page":"CD003264","article-title":"Growth hormone for children with chronic kidney disease.","volume":"4","author":"Vimalachandra","year":"2001","journal-title":"Cochrane Database Syst Rev"},{"key":"R19-13-20210128","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1210\/jc.2005-0846","article-title":"Growth hormone in Turner syndrome: twenty years after, what can we tell our patients.","volume":"90","author":"Carel","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"R20-13-20210128","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1210\/jc.2007-1723","article-title":"Long-term safety of recombinant human growth hormone in Turner syndrome.","volume":"93","author":"Bolar","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"R21-13-20210128","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1530\/eje.0.151s055","article-title":"Lessons from the national cooperative growth study.","volume":"151","author":"Wyatt","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"R22-13-20210128","first-page":"68","article-title":"Safety and efficacy of growth hormone therapy in childhood.","volume":"2","author":"Bowlby","year":"2004","journal-title":"Pediatr Endocrinol Rev"},{"key":"R23-13-20210128","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jpeds.2008.07.058","article-title":"Retrospective study of the potential benefits and adverse events during growth hormone treatment in children with Prader-Willi syndrome.","volume":"154","author":"Fillion","year":"2009","journal-title":"J Pediatr"},{"key":"R24-13-20210128","first-page":"1035","article-title":"Growth hormone safety update from the National Cooperative Growth Study.","volume":"13","author":"Maneatis","year":"2000","journal-title":"J Pediatr Endocrinol Metab"},{"key":"R25-13-20210128","first-page":"1704","article-title":"Safety of recombinant deoxyribonucleic acid-derived growth hormone: The National Cooperative Growth Study experience.","volume":"81","author":"Blethen","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"R26-13-20210128","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/bmt.2009.31","article-title":"A Short-term growth hormone treatment in children with Hurler syndrome after hematopoietic cell transplantation.","volume":"44","author":"Polgreen","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"R27-13-20210128","first-page":"387","article-title":"Carpal tunnel syndrome in children.","volume":"69","author":"Van Meir","year":"2003","journal-title":"Acta Orthop Belg"},{"key":"R28-13-20210128","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0266-7681(96)80023-4","article-title":"Carpal tunnel syndrome in children and adolescents with no history of trauma.","volume":"21","author":"Al-Qattan","year":"1996","journal-title":"J Hand Surg Br"},{"key":"R30-13-20210128","doi-asserted-by":"crossref","first-page":"S167","DOI":"10.1507\/endocrj.45.Suppl_S167","article-title":"Slipped capital femoral epiphysis, Perthes disease and scoliosis in children with growth hormone deficiency.","volume":"45","author":"Yoshikazu","year":"1998","journal-title":"Endocr J"},{"key":"R31-13-20210128","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3109\/17453677608989717","article-title":"Necrosis of the femoral capital epiphysis occurring during human growth hormone therapy.","volume":"47","author":"Bjkerkreim","year":"1976","journal-title":"Acta Orthop Scand"},{"key":"R33-13-20210128","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3109\/17453677809005763","article-title":"Progression of a structural scoliosis during treatment with growth hormone. A case report.","volume":"49","author":"Dymling","year":"1978","journal-title":"Acta Orthop Scand"},{"key":"R34-13-20210128","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1097\/01241398-199711000-00003","article-title":"Scoliosis in patients treated with growth hormone.","volume":"17","author":"Wang","year":"1997","journal-title":"J Pediatr Orthop"},{"key":"R35-13-20210128","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.2105\/AJPH.75.12.1377","article-title":"Age- and sex-specific prevalence of scoliosis and the value of school screening programs.","volume":"75","author":"Morais","year":"1985","journal-title":"Am J Public Health"},{"key":"R36-13-20210128","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1210\/jc.2009-0178","article-title":"Long-term safety of recombinant human growth hormone in children.","volume":"95","author":"Bell","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"R37-13-20210128","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1365-2265.2006.02570.x","article-title":"KIGS International Board Growth hormone treatment and adverse events in Prader-Willi syndrome: data from KIGS the Pfizer International Growth Database.","volume":"65","author":"Craig","year":"2006","journal-title":"Clin Endocrinol"},{"key":"R38-13-20210128","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1097\/01241398-200111000-00012","article-title":"Increased prevalence of scoliosis in turner syndrome.","volume":"21","author":"Kim","year":"2001","journal-title":"J Pediatr Orthop"},{"key":"R39-13-20210128","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1469-8749.1981.tb02441.x","article-title":"Prader-Willi syndrome and scoliosis.","volume":"23","author":"Holm","year":"1981","journal-title":"Dev Med Child Neurol"},{"key":"R40-13-20210128","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/01.bpo.0000226282.01202.4f","article-title":"Prader-Willi syndrome: clinical concerns for the orthopaedic surgeon.","volume":"26","author":"Kroonen","year":"2006","journal-title":"J Pediatr Orthop"},{"key":"R41-13-20210128","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/ajmg.a.31295","article-title":"Growth hormone therapy and scoliosis in patients with Prader-Willi syndrome.","volume":"140","author":"Nagai","year":"2006","journal-title":"Am J Med Genet A"},{"key":"R42-13-20210128","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.spinee.2009.06.017","article-title":"Epidemiological aspects of scoliosis in a cohort of Japanese patients with Prader-Willi syndrome.","volume":"9","author":"Nakamura","year":"2009","journal-title":"Spine J"},{"key":"R43-13-20210128","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1097\/00007890-199510150-00007","article-title":"Differences in linear growth and cortisol production between liver and renal transplant recipients on similar immunosuppression.","volume":"60","author":"Sarna","year":"1995","journal-title":"Transplantation"},{"key":"R44-13-20210128","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1600-6143.2005.01135.x","article-title":"Scoliosis after solid organ transplantation in children and adolescents.","volume":"6","author":"Helenius","year":"2006","journal-title":"Am J Transplant"},{"key":"R45-13-20210128","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.2106\/00004623-197052060-00013","article-title":"The incidence and distribution of slipped capital femoral epiphysis in Connecticut and Southwestern United States.","volume":"52","author":"Kelsey","year":"1970","journal-title":"J Bone Joint Surg"},{"key":"R46-13-20210128","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3109\/17453676908989514","article-title":"The incidence of slipped capital femoral epiphysis.","volume":"40","author":"Henrikson","year":"1969","journal-title":"Acta Orthop Scand"},{"key":"R47-13-20210128","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/01241398-198803000-00013","article-title":"Maturation factors in slipped capital femoral epiphysis.","volume":"8","author":"Wilcox","year":"1988","journal-title":"J Pediatr Orthop"},{"key":"R48-13-20210128","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1302\/0301-620X.56B4.703","article-title":"Slipped femoral capital epiphysis occurring during growth hormone therapy. Report of a case.","volume":"56","author":"Rennie","year":"1974","journal-title":"J Bone Joint Surg Br"},{"key":"R49-13-20210128","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.2106\/00004623-197456080-00026","article-title":"Slipped upper femoral epiphysis following treatment with human growth hormone.","volume":"56","author":"Fidler","year":"1974","journal-title":"J Bone Joint Surg Am"},{"key":"R50-13-20210128","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1515\/JPEM.1995.8.4.243","article-title":"Adverse events during growth hormone therapy.","volume":"8","author":"Cowell","year":"1995","journal-title":"J Pediatr Endocrinol Metab"},{"key":"R51-13-20210128","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000185006","article-title":"Slipped capital femoral epiphysis in children treated with growth hormone. A summary of the National Cooperative Growth Study experience.","volume":"46","author":"Blethen","year":"1996","journal-title":"Horm Res"},{"key":"R52-13-20210128","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/01.bpo.0000217718.10728.70","article-title":"The epidemiology of slipped capital femoral epiphysis: an update.","volume":"26","author":"Lehmann","year":"2006","journal-title":"J Pediatr Orthop"},{"key":"R53-13-20210128","first-page":"S126","article-title":"Bone disease in patients receiving growth hormone.","volume":"53","author":"Watkins","year":"1996","journal-title":"Kidney Int Suppl"},{"key":"R54-13-20210128","doi-asserted-by":"crossref","first-page":"197","DOI":"10.7326\/0003-4819-133-3-200008010-00011","article-title":"The pathology of median neuropathy in acromegaly.","volume":"133","author":"Jenkins","year":"2000","journal-title":"Ann Intern Med"},{"key":"R56-13-20210128","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1007\/s00467-009-1183-0","article-title":"The effect of rhGH on height velocity and BMI in children with CKD: a report of the NAPRTCS registry.","volume":"24","author":"Seikaly","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"R57-13-20210128","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1210\/jc.2007-1581","article-title":"Height velocity targets from the national cooperative growth study for first-year growth hormone responses in short children.","volume":"93","author":"Bakker","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"R58-13-20210128","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1302\/0301-620X.32B1.5","article-title":"The endocrine basis for slipping of the upper femoral epiphysis. An experimental study.","volume":"32-B","author":"Harris","year":"1950","journal-title":"J Bone Joint Surg"},{"key":"R59-13-20210128","first-page":"497","article-title":"Effects of exogenous growth hormone on growth plate cartilage in rats.","volume":"141","author":"Rappaport","year":"1987","journal-title":"Am J Dis Child"}],"container-title":["Journal of Pediatric Orthopaedics B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/BPB.0b013e32833ed967","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:56:35Z","timestamp":1786042595000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01202412-201101000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/bpb.0b013e32833ed967","relation":{},"ISSN":["1060-152X"],"issn-type":[{"value":"1060-152X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}